GNFT

GENFIT S.A. American Depositary Shares (GNFT)

About GENFIT S.A. American Depositary Shares (GNFT)

Genfit SA is a biopharmaceutical company involved in drug discovery and development for the early diagnosis, prevention and treatment of cardiometabolic diseases. The company focuses on the discovery and development of drug candidates in areas of high unmet medical needs corresponding to a lack of suitable treatments. It focuses on medicines to market for patients with metabolic, inflammatory, autoimmune and fibrotic diseases that affect the liver. The company was founded by Jean-François Mouney, Florence Séjourné, and Bart Staels in September 1999 and is headquartered in Loos, France.

Details

Daily high
$6.10
Daily low
$5.63
Price at open
$5.63
52 Week High
$6.08
52 Week Low
$2.97
Market cap
301.8M
Dividend yield
0.00%
Volume
15,049
Avg. volume
26,319
P/E ratio
12.51

GENFIT S.A. American Depositary Shares News

Details

Daily high
$6.10
Daily low
$5.63
Price at open
$5.63
52 Week High
$6.08
52 Week Low
$2.97
Market cap
301.8M
Dividend yield
0.00%
Volume
15,049
Avg. volume
26,319
P/E ratio
12.51